Inspire Medical Systems, Inc. (NYSE:INSP Get Rating) CTO John Rondoni sold 1,170 shares of the companys stock in a transaction dated Tuesday, January 3rd. The stock was sold at an average price of $256.00, for a total transaction of $299,520.00. Following the completion of the sale, the chief ...

MINNEAPOLIS, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and fiscal 2022 after the close of trading on Tuesday, February 7. Inspires management team will host a corresponding conference call beginning at...

MINNEAPOLIS, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced certain ...

Inspire Medical Systems (NYSE:INSP Get Rating) had its price objective upped by Truist Financial from $270.00 to $308.00 in a research report sent to investors on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Several other research firms have also ...

Inspire Medical Systems, Inc. (NYSE:INSP Get Rating) Director Marilyn C. Nelson sold 25,211 shares of Inspire Medical Systems stock in a transaction on Friday, December 16th. The shares were sold at an average price of $244.77, for a total value of $6,170,896.47. Following the completion of ...